Back to search
FDAFDA · Food and drugs·Recall number D-1412-2012

Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18

Published July 18, 2012 · Recall initiated: June 4, 2012

Summary

FDA records drug Class II recall D-1412-2012, published July 18, 2012 and initiated June 4, 2012. Recalling firm: GlaxoSmithKline Inc; Status: Terminated; Reported quantity: 14,465 bottles; Lot: Lot #0ZP5128 exp; 8/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GlaxoSmithKline Inc
Distributor
Nationwide
Lot
Lot #0ZP5128 exp; 8/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18 recalled?

Yes. FDA published recall D-1412-2012 on July 18, 2012. Reported hazard: Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter